Cite

HARVARD Citation

    Barg, A. et al. (2019). Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors—a single‐center cohort. Pediatric blood & cancer. 66 (11), p. n/a. [Online]. 
  
Back to record